Clarithromycin Susceptibility-Guided Treatment of Helicobacter Pylori Infection
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess the safety and efficacy of clarithromycin
susceptibility-guided therapy as the first line treatment for H pylori infection compared
with empirical bismuth-containing quadruple therapy.